Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context

E. R. Soriano; Claudio Galarza-Maldonado; M. H. Cardiel; B. A. Pons-Estel; L. Massardo; C. V. Caballero-Uribe; A. F. Achurra-Castillo; L. A. Barile-Fabris; J. Chávez-Corrales; J. F. Díaz-Coto; M. H. Esteva-Spinetti; M. Guibert-Toledano; Irazoque F. Palazuelos; M. W. Keiserman; A. V. Lomonte; L. M.H. Mota; C. Pineda Villaseñor; G. S. Alarcón

doi:10.1093/rheumatology/ken015a

Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context

E. R. Soriano, Claudio Galarza-Maldonado^*, M. H. Cardiel, B. A. Pons-Estel, L. Massardo, C. V. Caballero-Uribe, A. F. Achurra-Castillo, L. A. Barile-Fabris, J. Chávez-Corrales, J. F. Díaz-Coto, M. H. Esteva-Spinetti, M. Guibert-Toledano, Irazoque F. Palazuelos, M. W. Keiserman, A. V. Lomonte, L. M.H. Mota, C. Pineda Villaseñor, G. S. Alarcón

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Original language	English
Pages (from-to)	1097-1099
Number of pages	3
Journal	Rheumatology (United Kingdom)
Volume	47
Issue number	7
DOIs	https://doi.org/10.1093/rheumatology/ken015a
State	Published - 2008
Externally published	Yes

Bibliographical note

Funding Information:
Disclosure statement: E.R.S. has received grants from Abbott and support to attend ACR from Wyeth. M.H.C. has conducted clinical trials with rituximab as a principal investigator. L.M.H.M. has been a co-investigator in rituximab clinical trials for Roche and has received financial support for Medical Congress from Roche. C.G.-M. has been a principle investigator in biologic products clinical trials for Roche and Abbott. He has also received honoraria as an Advisory Board member for Wyeth. All other authors have declared no conflicts of interest.

Funding Information:
Funding: The conceptualization of this consensus paper was made possible by an unrestricted grant from Roche.

ASJC Scopus subject areas

Rheumatology
Pharmacology (medical)

Access to Document

10.1093/rheumatology/ken015a

Cite this

Soriano, E. R., Galarza-Maldonado, C., Cardiel, M. H., Pons-Estel, B. A., Massardo, L., Caballero-Uribe, C. V., Achurra-Castillo, A. F., Barile-Fabris, L. A., Chávez-Corrales, J., Díaz-Coto, J. F., Esteva-Spinetti, M. H., Guibert-Toledano, M., Palazuelos, I. F., Keiserman, M. W., Lomonte, A. V., Mota, L. M. H., Pineda Villaseñor, C., & Alarcón, G. S. (2008). Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context. Rheumatology (United Kingdom), 47(7), 1097-1099. https://doi.org/10.1093/rheumatology/ken015a

@article{569451efbe214832a99e3ba9031120b0,

title = "Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context",

keywords = "Anti-CD20 antibody, Biologic therapy, Latin America, Rheumatoid arthritis, Rituximab, Treatment guidelines",

author = "Soriano, {E. R.} and Claudio Galarza-Maldonado and Cardiel, {M. H.} and Pons-Estel, {B. A.} and L. Massardo and Caballero-Uribe, {C. V.} and Achurra-Castillo, {A. F.} and Barile-Fabris, {L. A.} and J. Ch{\'a}vez-Corrales and D{\'i}az-Coto, {J. F.} and Esteva-Spinetti, {M. H.} and M. Guibert-Toledano and Palazuelos, {Irazoque F.} and Keiserman, {M. W.} and Lomonte, {A. V.} and Mota, {L. M.H.} and {Pineda Villase{\~n}or}, C. and Alarc{\'o}n, {G. S.}",

note = "Funding Information: Disclosure statement: E.R.S. has received grants from Abbott and support to attend ACR from Wyeth. M.H.C. has conducted clinical trials with rituximab as a principal investigator. L.M.H.M. has been a co-investigator in rituximab clinical trials for Roche and has received financial support for Medical Congress from Roche. C.G.-M. has been a principle investigator in biologic products clinical trials for Roche and Abbott. He has also received honoraria as an Advisory Board member for Wyeth. All other authors have declared no conflicts of interest. Funding Information: Funding: The conceptualization of this consensus paper was made possible by an unrestricted grant from Roche.",

year = "2008",

month = jul,

doi = "10.1093/rheumatology/ken015a",

language = "English",

volume = "47",

pages = "1097--1099",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "7",

}

Soriano, ER, Galarza-Maldonado, C, Cardiel, MH, Pons-Estel, BA, Massardo, L, Caballero-Uribe, CV, Achurra-Castillo, AF, Barile-Fabris, LA, Chávez-Corrales, J, Díaz-Coto, JF, Esteva-Spinetti, MH, Guibert-Toledano, M, Palazuelos, IF, Keiserman, MW, Lomonte, AV, Mota, LMH, Pineda Villaseñor, C & Alarcón, GS 2008, 'Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context', Rheumatology (United Kingdom), vol. 47, no. 7, pp. 1097-1099. https://doi.org/10.1093/rheumatology/ken015a

TY - JOUR

T1 - Use of rituximab for the treatment of rheumatoid arthritis

T2 - The Latin American context

AU - Soriano, E. R.

AU - Galarza-Maldonado, Claudio

AU - Cardiel, M. H.

AU - Pons-Estel, B. A.

AU - Massardo, L.

AU - Caballero-Uribe, C. V.

AU - Achurra-Castillo, A. F.

AU - Barile-Fabris, L. A.

AU - Chávez-Corrales, J.

AU - Díaz-Coto, J. F.

AU - Esteva-Spinetti, M. H.

AU - Guibert-Toledano, M.

AU - Palazuelos, Irazoque F.

AU - Keiserman, M. W.

AU - Lomonte, A. V.

AU - Mota, L. M.H.

AU - Pineda Villaseñor, C.

AU - Alarcón, G. S.

N1 - Funding Information: Disclosure statement: E.R.S. has received grants from Abbott and support to attend ACR from Wyeth. M.H.C. has conducted clinical trials with rituximab as a principal investigator. L.M.H.M. has been a co-investigator in rituximab clinical trials for Roche and has received financial support for Medical Congress from Roche. C.G.-M. has been a principle investigator in biologic products clinical trials for Roche and Abbott. He has also received honoraria as an Advisory Board member for Wyeth. All other authors have declared no conflicts of interest. Funding Information: Funding: The conceptualization of this consensus paper was made possible by an unrestricted grant from Roche.

PY - 2008/7

Y1 - 2008/7

KW - Anti-CD20 antibody

KW - Biologic therapy

KW - Latin America

KW - Rheumatoid arthritis

KW - Rituximab

KW - Treatment guidelines

UR - http://www.scopus.com/inward/record.url?scp=45749112561&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/ken015a

DO - 10.1093/rheumatology/ken015a

M3 - Article

C2 - 18463144

AN - SCOPUS:45749112561

SN - 1462-0324

VL - 47

SP - 1097

EP - 1099

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 7

ER -

Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this